Genflow Biosciences plc (LON:GENF – Get Free Report) shot up 1.9% during mid-day trading on Friday . The stock traded as high as GBX 2.10 and last traded at GBX 1.91. 514,884 shares traded hands during trading, a decline of 90% from the average session volume of 5,074,950 shares. The stock had previously closed at GBX 1.88.
Genflow Biosciences Price Performance
The stock has a market capitalization of £9.87 million, a P/E ratio of -3.98 and a beta of 2.37. The company’s 50-day simple moving average is GBX 1.85 and its 200-day simple moving average is GBX 1.18.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its quarterly earnings data on Tuesday, September 30th. The company reported GBX (0.19) EPS for the quarter. Genflow Biosciences had a net margin of 778.46% and a negative return on equity of 208.12%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
- Five stocks we like better than Genflow Biosciences
- What Are Dividend Achievers? An Introduction
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- The Significance of Brokerage Rankings in Stock Selection
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- Election Stocks: How Elections Affect the Stock Market
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
